Today we have an extremely speculative idea.: take stock of mobile game developer Nexters (NASDAQ: WHERE), to capitalize on the growth of this business. Growth potential and validity: 22% behind 12 Months; 35% behind 2 of the year; 15% per annum during 15 years. Why stocks can go up: mobile games are the future. And the future is bleak.
Teads company, spun off from Altice to offer advertisers and publishers a digital ad platform, announced the withdrawal of the appeal for the IPO.
RenovoRx company, which develops a honey device to heal decent tumors, attracted 17 million dollars, releasing 1,85 million packages of 9 Dollars, low cost of the revised spectrum from 9 to 11 Dollars. Each package consists of one ordinary share and 1 order, due on 10,80 Dollars.
Restrictions will affect large organizations, which store a large size of user data, tells WSJ. Beijing wants to introduce new rules by the end of the year, in the fourth quarter. The agency responsible for information security has already approved two new requirements last week..
Now we have an extremely speculative thought: take shares in software manufacturer C3 AI (NYSE: TO THE), to get income on their rebound after a powerful fall. Growth potential and duration : 22,5 % behind 15 Months; thirty eight percent in two years; 249% fifteen years. Why stocks can go up: AI is a promising topic.
The stock market takes a breather after that, as for the last 17 months demonstrated his impeccable work.
Virgin Orbit, spin-off to launch Virgin Galactic satellites by Sir Richard Branson, preparing to become public, announcing today, that will merge with SPAC for placement on Nasdaq. When to wait for an IPO? The company merges with special purpose acquisition company NextGen Acquisition Corp. II.
Teads company, spun off from Altice to offer advertisers and publishers a digital advertising platform, announced the withdrawal of the application for IPO. Initially, the company applied for 751 million dollars, releasing 38,5 million shares (100% insider) at a price from 18 to 21 dollar, however, postponed the placement of shares at the end of July.
RenovoRx company, developing a medical device for the treatment of solid tumors, attracted 17 million dollars, releasing 1,85 million packages of 9 Dollars, minimum price of the revised range from 9 to 11 Dollars. Each package consists of one ordinary share and one order, due on 10,80 Dollars.
SeqLL Company, developing molecular sequencing technology, attracted 13 million dollars, releasing 3,1 million packages of 4,75 dollar, average price of the stated range from 4,25 to 5,25 Dollars. Each package includes one ordinary share